Clinical and molecular analysis of stargardt disease with preserved foveal structure and function

Kaoru Fujinami, Panagiotis I. Sergouniotis, Alice E. Davidson, Genevieve Wright, Ravinder K. Chana, Kazushige Tsunoda, Kazuo Tsubota, Catherine A. Egan, Anthony G. Robson, Anthony T. Moore, Graham E. Holder, Michel Michaelides, Andrew R. Webster

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Purpose: To describe a cohort of patients with Stargardt disease who show a foveal-sparing phenotype. Design: Retrospective case series. Methods: The foveal-sparing phenotype was defined as foveal preservation on autofluorescence imaging, despite a retinopathy otherwise consistent with Stargardt disease. Forty such individuals were ascertained and a full ophthalmic examination was undertaken. Following mutation screening of ABCA4, the molecular findings were compared with those of patients with Stargardt disease but no foveal sparing. Results: The median age of onset and age at examination of 40 patients with the foveal-sparing phenotype were 43.5 and 46.5 years. The median logMAR visual acuity was 0.18. Twenty-two patients (22/40, 55%) had patchy parafoveal atrophy and flecks; 8 (20%) had numerous flecks at the posterior pole without atrophy; 7 (17.5%) had mottled retinal pigment epithelial changes; 2 (5%) had multiple atrophic lesions, extending beyond the arcades; and 1 (2.5%) had a bull's-eye appearance. The median central foveal thickness assessed with spectral-domain optical coherence tomographic images was 183.0 μm (n = 33), with outer retinal tubulation observed in 15 (45%). Twenty-two of 33 subjects (67%) had electrophysiological evidence of macular dysfunction without generalized retinal dysfunction. Disease-causing variants were found in 31 patients (31/40, 78%). There was a higher prevalence of the variant p.Arg2030Gln in the cohort with foveal sparing compared to the group with foveal atrophy (6.45% vs 1.07%). Conclusions: The distinct clinical and molecular characteristics of patients with the foveal-sparing phenotype are described. The presence of 2 distinct phenotypes of Stargardt disease (foveal sparing and foveal atrophy) suggests that there may be more than 1 disease mechanism in ABCA4 retinopathy.

Original languageEnglish
JournalAmerican Journal of Ophthalmology
Volume156
Issue number3
DOIs
Publication statusPublished - 2013 Sep

Fingerprint

Atrophy
Phenotype
Retinal Pigments
Optical Imaging
Age of Onset
Visual Acuity
Stargardt disease 1
Mutation
Flecks

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Fujinami, K., Sergouniotis, P. I., Davidson, A. E., Wright, G., Chana, R. K., Tsunoda, K., ... Webster, A. R. (2013). Clinical and molecular analysis of stargardt disease with preserved foveal structure and function. American Journal of Ophthalmology, 156(3). https://doi.org/10.1016/j.ajo.2013.05.003

Clinical and molecular analysis of stargardt disease with preserved foveal structure and function. / Fujinami, Kaoru; Sergouniotis, Panagiotis I.; Davidson, Alice E.; Wright, Genevieve; Chana, Ravinder K.; Tsunoda, Kazushige; Tsubota, Kazuo; Egan, Catherine A.; Robson, Anthony G.; Moore, Anthony T.; Holder, Graham E.; Michaelides, Michel; Webster, Andrew R.

In: American Journal of Ophthalmology, Vol. 156, No. 3, 09.2013.

Research output: Contribution to journalArticle

Fujinami, K, Sergouniotis, PI, Davidson, AE, Wright, G, Chana, RK, Tsunoda, K, Tsubota, K, Egan, CA, Robson, AG, Moore, AT, Holder, GE, Michaelides, M & Webster, AR 2013, 'Clinical and molecular analysis of stargardt disease with preserved foveal structure and function', American Journal of Ophthalmology, vol. 156, no. 3. https://doi.org/10.1016/j.ajo.2013.05.003
Fujinami, Kaoru ; Sergouniotis, Panagiotis I. ; Davidson, Alice E. ; Wright, Genevieve ; Chana, Ravinder K. ; Tsunoda, Kazushige ; Tsubota, Kazuo ; Egan, Catherine A. ; Robson, Anthony G. ; Moore, Anthony T. ; Holder, Graham E. ; Michaelides, Michel ; Webster, Andrew R. / Clinical and molecular analysis of stargardt disease with preserved foveal structure and function. In: American Journal of Ophthalmology. 2013 ; Vol. 156, No. 3.
@article{097f334d0d0b4d588500413c598f9d00,
title = "Clinical and molecular analysis of stargardt disease with preserved foveal structure and function",
abstract = "Purpose: To describe a cohort of patients with Stargardt disease who show a foveal-sparing phenotype. Design: Retrospective case series. Methods: The foveal-sparing phenotype was defined as foveal preservation on autofluorescence imaging, despite a retinopathy otherwise consistent with Stargardt disease. Forty such individuals were ascertained and a full ophthalmic examination was undertaken. Following mutation screening of ABCA4, the molecular findings were compared with those of patients with Stargardt disease but no foveal sparing. Results: The median age of onset and age at examination of 40 patients with the foveal-sparing phenotype were 43.5 and 46.5 years. The median logMAR visual acuity was 0.18. Twenty-two patients (22/40, 55{\%}) had patchy parafoveal atrophy and flecks; 8 (20{\%}) had numerous flecks at the posterior pole without atrophy; 7 (17.5{\%}) had mottled retinal pigment epithelial changes; 2 (5{\%}) had multiple atrophic lesions, extending beyond the arcades; and 1 (2.5{\%}) had a bull's-eye appearance. The median central foveal thickness assessed with spectral-domain optical coherence tomographic images was 183.0 μm (n = 33), with outer retinal tubulation observed in 15 (45{\%}). Twenty-two of 33 subjects (67{\%}) had electrophysiological evidence of macular dysfunction without generalized retinal dysfunction. Disease-causing variants were found in 31 patients (31/40, 78{\%}). There was a higher prevalence of the variant p.Arg2030Gln in the cohort with foveal sparing compared to the group with foveal atrophy (6.45{\%} vs 1.07{\%}). Conclusions: The distinct clinical and molecular characteristics of patients with the foveal-sparing phenotype are described. The presence of 2 distinct phenotypes of Stargardt disease (foveal sparing and foveal atrophy) suggests that there may be more than 1 disease mechanism in ABCA4 retinopathy.",
author = "Kaoru Fujinami and Sergouniotis, {Panagiotis I.} and Davidson, {Alice E.} and Genevieve Wright and Chana, {Ravinder K.} and Kazushige Tsunoda and Kazuo Tsubota and Egan, {Catherine A.} and Robson, {Anthony G.} and Moore, {Anthony T.} and Holder, {Graham E.} and Michel Michaelides and Webster, {Andrew R.}",
year = "2013",
month = "9",
doi = "10.1016/j.ajo.2013.05.003",
language = "English",
volume = "156",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Clinical and molecular analysis of stargardt disease with preserved foveal structure and function

AU - Fujinami, Kaoru

AU - Sergouniotis, Panagiotis I.

AU - Davidson, Alice E.

AU - Wright, Genevieve

AU - Chana, Ravinder K.

AU - Tsunoda, Kazushige

AU - Tsubota, Kazuo

AU - Egan, Catherine A.

AU - Robson, Anthony G.

AU - Moore, Anthony T.

AU - Holder, Graham E.

AU - Michaelides, Michel

AU - Webster, Andrew R.

PY - 2013/9

Y1 - 2013/9

N2 - Purpose: To describe a cohort of patients with Stargardt disease who show a foveal-sparing phenotype. Design: Retrospective case series. Methods: The foveal-sparing phenotype was defined as foveal preservation on autofluorescence imaging, despite a retinopathy otherwise consistent with Stargardt disease. Forty such individuals were ascertained and a full ophthalmic examination was undertaken. Following mutation screening of ABCA4, the molecular findings were compared with those of patients with Stargardt disease but no foveal sparing. Results: The median age of onset and age at examination of 40 patients with the foveal-sparing phenotype were 43.5 and 46.5 years. The median logMAR visual acuity was 0.18. Twenty-two patients (22/40, 55%) had patchy parafoveal atrophy and flecks; 8 (20%) had numerous flecks at the posterior pole without atrophy; 7 (17.5%) had mottled retinal pigment epithelial changes; 2 (5%) had multiple atrophic lesions, extending beyond the arcades; and 1 (2.5%) had a bull's-eye appearance. The median central foveal thickness assessed with spectral-domain optical coherence tomographic images was 183.0 μm (n = 33), with outer retinal tubulation observed in 15 (45%). Twenty-two of 33 subjects (67%) had electrophysiological evidence of macular dysfunction without generalized retinal dysfunction. Disease-causing variants were found in 31 patients (31/40, 78%). There was a higher prevalence of the variant p.Arg2030Gln in the cohort with foveal sparing compared to the group with foveal atrophy (6.45% vs 1.07%). Conclusions: The distinct clinical and molecular characteristics of patients with the foveal-sparing phenotype are described. The presence of 2 distinct phenotypes of Stargardt disease (foveal sparing and foveal atrophy) suggests that there may be more than 1 disease mechanism in ABCA4 retinopathy.

AB - Purpose: To describe a cohort of patients with Stargardt disease who show a foveal-sparing phenotype. Design: Retrospective case series. Methods: The foveal-sparing phenotype was defined as foveal preservation on autofluorescence imaging, despite a retinopathy otherwise consistent with Stargardt disease. Forty such individuals were ascertained and a full ophthalmic examination was undertaken. Following mutation screening of ABCA4, the molecular findings were compared with those of patients with Stargardt disease but no foveal sparing. Results: The median age of onset and age at examination of 40 patients with the foveal-sparing phenotype were 43.5 and 46.5 years. The median logMAR visual acuity was 0.18. Twenty-two patients (22/40, 55%) had patchy parafoveal atrophy and flecks; 8 (20%) had numerous flecks at the posterior pole without atrophy; 7 (17.5%) had mottled retinal pigment epithelial changes; 2 (5%) had multiple atrophic lesions, extending beyond the arcades; and 1 (2.5%) had a bull's-eye appearance. The median central foveal thickness assessed with spectral-domain optical coherence tomographic images was 183.0 μm (n = 33), with outer retinal tubulation observed in 15 (45%). Twenty-two of 33 subjects (67%) had electrophysiological evidence of macular dysfunction without generalized retinal dysfunction. Disease-causing variants were found in 31 patients (31/40, 78%). There was a higher prevalence of the variant p.Arg2030Gln in the cohort with foveal sparing compared to the group with foveal atrophy (6.45% vs 1.07%). Conclusions: The distinct clinical and molecular characteristics of patients with the foveal-sparing phenotype are described. The presence of 2 distinct phenotypes of Stargardt disease (foveal sparing and foveal atrophy) suggests that there may be more than 1 disease mechanism in ABCA4 retinopathy.

UR - http://www.scopus.com/inward/record.url?scp=84882263713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882263713&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2013.05.003

DO - 10.1016/j.ajo.2013.05.003

M3 - Article

VL - 156

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 3

ER -